Open AccessParticipants’ Treatment Perspectives on a Clinical Trial on the Use of Extended-Release Naltrexone for Substance Use Disorders: Considerations for Future Clinical Research
Author(s) -
Geoff Bardwell,
Kaitlyn Jaffe,
P Todd Korthuis,
Lindsey Richardson
Publication year - 2020
Publication title -
journal of addiction medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 42
eISSN - 1935-3227
pISSN - 1932-0620
DOI - 10.1097/adm.0000000000000772
Subject(s) - medicine , psychological intervention , apprehension , clinical trial , qualitative research , naltrexone , clinical psychology , randomized controlled trial , perception , participant observation , psychiatry , psychology , opioid , social science , receptor , surgery , pathology , neuroscience , sociology , cognitive psychology , anthropology
We undertook this study to understand participants' perceptions of their assigned treatment in a randomized control trial examining the use of extended-release naltrexone versus treatment as usual for substance use disorders.